Anebulo Pharmaceuticals Inc (ANEB)
0.43
-0.76%
Anebulo Pharmaceuticals Inc (ANEB) is currently trading at $0.43. This represents a loss of 0.76% from the previous session. With a market capitalization of $0.02B, ANEB is a key component of the Health Care sector. Investors looking to trade ANEB should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ANEB commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Anebulo Pharmaceuticals Inc (ANEB) shows a bearish trend. Analysts are watching the 0.46 level closely.
Fundamentals
Mkt Cap0.02B
P/E Ratio0.0000
Volume50,509
60-Day Technical Chart
Advanced Charting
Need more indicators for ANEB? Use the world's #1 platform.
Open ANEB on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $0
| Metric |
ANEB -0.76% |
SGMO -0.53% |
OPTT -2.81% |
|---|---|---|---|
| Price | $0.43 | $0.47 | $0.41 |
| Mkt Cap | $0.02B | $0.17B | $0.08B |
| - | View → | View → |
Latest Headlines
Anebulo Pharma plans Nasdaq exit to cut SEC reporting costs
Stock Titan • Feb 6, 2026
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
Business Wire • Jul 23, 2025
Drug developer drops reverse split, plans cash buyback to go private
Stock Titan • Dec 22, 2025
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
Business Wire • Sep 29, 2025
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
Business Wire • Nov 13, 2025
● Gemini Agentic AI Analyst Insight for ANEB
Market Education
- Canada Pension Plan - Top Stocks Nov 20, 2023
- Candlestick Patterns every trader should know Apr 20, 2021
- Finding Stocks in the Squeeze Zone: Using Finviz Jun 2, 2024
External Research